Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: August 9, 2024
Reporting Period: This filing reports on events occurring on August 9, 2024, specifically regarding upcoming investor presentations.
Key Financial Metrics
This Form 8-K does not contain specific financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves as a disclosure notice for an investor presentation rather than a financial report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses that executive officers have scheduled upcoming presentations to investors and analysts and intend to utilize the material provided in Exhibit 99.1.
Guidance, Outlook, and Risks
Management Commentary: The company is preparing for investor and analyst presentations using the attached August 2024 Investor Presentation (Exhibit 99.1).
Regulatory Status: The information provided in Item 7.01 and Exhibit 99.1 is furnished pursuant to Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated August 2024) for detailed financial data and strategic outlook.
- Verify the content of upcoming investor presentations to ensure alignment with the furnished materials.
- Note that the information in this 8-K is not legally "filed" under Section 18 of the Exchange Act.
- Confirm the trading symbol (KIDS) and exchange (Nasdaq Global Market) for the company's common stock.